Literature DB >> 9572487

The transcription of the intercellular adhesion molecule-1 is regulated by Ets transcription factors.

Y de Launoit1, M Audette, H Pelczar, S Plaza, J L Baert.   

Abstract

The Ets family of transcription factors comprises several members which are involved to regulate gene transcription. Although several consensus binding sites for Ets proteins can be found in a wide series of promoter, only a limited number of them are indeed activated by these transcription factors. The human intercellular adhesion molecule-1 (ICAM-1) plays a crucial role in immune responses by enabling the binding of effector cells to various target cell types. ICAM-1 is constitutively expressed at different levels in the absence of stimuli in different cell types, and its expression is upregulated by several proinflammatory cytokines. We have here examined the transcriptional regulation of human ICAM-1 expression by Ets proteins, and more particularly by ERM, a member of this family of transcription factors. Transient transfection assays revealed that Ets-2 and ERM significantly activate the transcription of ICAM-1 promoter, whereas the less-related Ets family member, Spi-1/Pu.1, failed to do so. Transfection of a series of ICAM-1 promoter deletion mutants together with ERM expression plasmids have shown that an Ets responsive element is located within the first 176 bp upstream from the translational start site. Electrophoretic mobility shift assays and DNase I footprinting analysis have enabled us to identify two Ets binding sites at positions -158 and -138 from the ATG, respectively. Site directed mutagenesis of these elements has shown that the distal site is the major element required for the ERM-mediated activation of the ICAM-1 promoter. We can thus conclude that expression of ICAM-1 can be regulated by Ets transcription factors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572487     DOI: 10.1038/sj.onc.1201726

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

1.  EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.

Authors:  Janyaporn Phuchareon; Frank McCormick; David W Eisele; Osamu Tetsu
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

2.  Potentiation of tumor necrosis factor-induced NF-kappa B activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of I kappa B alpha.

Authors:  Emmanuelle Adam; Vincent Quivy; Françoise Bex; Alain Chariot; Yves Collette; Caroline Vanhulle; Sonia Schoonbroodt; Véronique Goffin; Thi Liên-Anh Nguyên; Geoffrey Gloire; Géraldine Carrard; Bertrand Friguet; Yvan De Launoit; Arsène Burny; Vincent Bours; Jacques Piette; Carine Van Lint
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

3.  Ectopic expression of the ets transcription factor ER81 in transgenic mouse mammary gland enhances both urokinase plasminogen activator and stromelysin-1 transcription.

Authors:  Sonia Netzer; Frauke Leenders; Patrick Dumont; Jean-Luc Baert; Yvan de Launoit
Journal:  Transgenic Res       Date:  2002-04       Impact factor: 2.788

4.  FGF-Regulated ETV Transcription Factors Control FGF-SHH Feedback Loop in Lung Branching.

Authors:  John C Herriges; Jamie M Verheyden; Zhen Zhang; Pengfei Sui; Ying Zhang; Matthew J Anderson; Deborah A Swing; Yan Zhang; Mark Lewandoski; Xin Sun
Journal:  Dev Cell       Date:  2015-11-09       Impact factor: 12.270

5.  The transcription factor Erg controls endothelial cell quiescence by repressing activity of nuclear factor (NF)-κB p65.

Authors:  Nicola H Dryden; Andrea Sperone; Silvia Martin-Almedina; Rebecca L Hannah; Graeme M Birdsey; Samia Taufiq Khan; Janice A Layhadi; Justin C Mason; Dorian O Haskard; Berthold Göttgens; Anna M Randi
Journal:  J Biol Chem       Date:  2012-02-15       Impact factor: 5.157

6.  Methylene-tetrahydrofolate reductase contributes to allergic airway disease.

Authors:  Kenneth R Eyring; Brent S Pedersen; Kenneth N Maclean; Sally P Stabler; Ivana V Yang; David A Schwartz
Journal:  PLoS One       Date:  2018-01-12       Impact factor: 3.240

Review 7.  ETS-targeted therapy: can it substitute for MEK inhibitors?

Authors:  Osamu Tetsu; Frank McCormick
Journal:  Clin Transl Med       Date:  2017-05-02

8.  The Mediator complex subunit MED25 is targeted by the N-terminal transactivation domain of the PEA3 group members.

Authors:  Alexis Verger; Jean-Luc Baert; Kathye Verreman; Frédérique Dewitte; Elisabeth Ferreira; Zoé Lens; Yvan de Launoit; Vincent Villeret; Didier Monté
Journal:  Nucleic Acids Res       Date:  2013-03-26       Impact factor: 16.971

9.  ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.

Authors:  G De la Houssaye; V Vieira; C Masson; F Beermann; J L Dufier; M Menasche; M Abitbol
Journal:  Mol Vis       Date:  2008-10-29       Impact factor: 2.367

10.  Plakophilin-3 catenin associates with the ETV1/ER81 transcription factor to positively modulate gene activity.

Authors:  William A Munoz; Moonsup Lee; Rachel K Miller; Zamal Ahmed; Hong Ji; Todd M Link; Gilbert R Lee; Malgorzata Kloc; John E Ladbury; Pierre D McCrea
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.